Indeed, in previous work, it was reported that a UHCL3 inhibitor was identified and could be further applied in treating non-small lung cancer, breast cancer and lung cancer;35,52 however, whether the suppressive effect of these inhibitors on UHCL3 occurs through the direct binding and targeting of UCHL3 remains to be determined. The gene discussed is UCHL3; the disease is breast cancer.